Why Johnson & Johnson Is Eyeing Protagonist Therapeutics: The Rationale
Source: SeekingAlpha
2025-10-13 10:09:05 ET
Thesis
It's been a busy week for Protagonist Therapeutics, Inc. (PGTX) in terms of news. They're a name that wouldn't have been on everyone's map before the interest shown by Johnson & Johnson ( JNJ ) ("J&J"); however, after last week, their stock has seen significant upside. Shares are now trading in the $80 range and have seen a 30% jump as a result of the news....
Read the full article on Seeking Alpha
For further details see:
Why Johnson & Johnson Is Eyeing Protagonist Therapeutics: The Rationale
Takeda Pharmaceutical Co Ltd
NASDAQ: TKPHF
TKPHF Trading
0.0% G/L:
$37.83 Last:
113 Volume:
$37.83 Open:
TKPHF Latest News
TKPHF Stock Data
$55,801,616,447
1,559,387,460
N/A
724
N/A
Pharmaceuticals
Healthcare
JP
Chuo-ku
